Worth Venture Partners’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-4,673
Closed -$201K 163
2020
Q2
$201K Sell
4,673
-1,904
-29% -$78.7K 0.1% 95
2020
Q1
$237K Buy
6,577
+1,066
+19% +$45.4K 0.15% 69
2019
Q4
$252K Sell
5,511
-703
-11% -$27.9K 0.13% 66
2019
Q3
$221K Sell
6,214
-797
-11% -$29.6K 0.13% 68
2019
Q2
$279K Sell
7,011
-1,624
-19% -$63.9K 0.16% 58
2019
Q1
$359K Buy
8,635
+133
+2% +$5.41K 0.2% 60
2018
Q4
$310K Buy
8,502
+3,871
+84% +$165K 0.24% 58
2018
Q3
$25K Buy
+4,631
New +$219K 0.02% 149
2018
Q1
Sell
-5,191
Closed -$226K 144
2017
Q4
$226K Buy
+5,191
New +$221K 0.26% 71
2017
Q2
Sell
-6,469
Closed -$271K 162
2017
Q1
$271K Buy
+6,469
New +$264K 0.25% 85

Other funds holding XPH